Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients

Obed A, Stern S, Jarrad A, Lorf T (2015)
World Journal of Gastroenterology 21(14): 4423-4426.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ;
Abstract
Alcoholic liver disease (ALD) is the second most common diagnosis among patients undergoing liver transplantation (LT). The recovery results of patients transplanted for ALD are often at least as good as those of patients transplanted for other diagnoses and better than those suffering from hepatitis C virus, cryptogenic cirrhosis, or hepatocellular carcinoma. In the case of medically non-responding patients with severe acute alcoholic hepatitis or acute-on chronic liver failure, the refusal of LT is often based on the lack of the required alcohol abstinence period of six months. The obligatory abidance of a period of abstinence as a transplant eligibility requirement for medically non-responding patients seems unfair and inhumane, since the majority of these patients will not survive the six-month abstinence period. Data from various studies have challenged the 6-mo rule, while excellent survival results of LT have been observed in selected patients with severe alcoholic hepatitis not responding to medical therapy. Patients with severe advanced ALD should have legal access to LT. The mere lack of pre-LT abstinence should not be an obstacle for being listed.
Publishing Year
ISSN
PUB-ID

Cite this

Obed A, Stern S, Jarrad A, Lorf T. Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients. World Journal of Gastroenterology. 2015;21(14):4423-4426.
Obed, A., Stern, S., Jarrad, A., & Lorf, T. (2015). Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients. World Journal of Gastroenterology, 21(14), 4423-4426.
Obed, A., Stern, S., Jarrad, A., and Lorf, T. (2015). Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients. World Journal of Gastroenterology 21, 4423-4426.
Obed, A., et al., 2015. Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients. World Journal of Gastroenterology, 21(14), p 4423-4426.
A. Obed, et al., “Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients”, World Journal of Gastroenterology, vol. 21, 2015, pp. 4423-4426.
Obed, A., Stern, S., Jarrad, A., Lorf, T.: Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients. World Journal of Gastroenterology. 21, 4423-4426 (2015).
Obed, Aiman, Stern, Steffen, Jarrad, Anwar, and Lorf, Thomas. “Six month abstinence rule for liver transplantation in severe alcoholic liver disease patients”. World Journal of Gastroenterology 21.14 (2015): 4423-4426.
This data publication is cited in the following publications:
This publication cites the following data publications:

39 References

Data provided by Europe PubMed Central.

Alcohol addiction: a molecular biology perspective.
Ferraguti G, Pascale E, Lucarelli M., Curr. Med. Chem. 22(6), 2015
PMID: 25544474
Long-term outcome of living donor liver transplantation for patients with alcoholic liver disease.
Ahn CS, Hwang S, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Park GC, Kang SH, Jung BH, Kim N, Lee SG., Transplant. Proc. 46(3), 2014
PMID: 24767343
Liver transplantation for alcoholic liver disease: evaluation of a selection protocol.
Anand AC, Ferraz-Neto BH, Nightingale P, Mirza DF, White AC, McMaster P, Neuberger JM., Hepatology 25(6), 1997
PMID: 9185771
Liver transplantation for alcoholic liver disease.
Anantharaju A, Van Thiel DH., Alcohol Res Health 27(3), 2003
PMID: 15535454
Public and professional attitudes to transplanting alcoholic patients.
Neuberger J., Liver Transpl. 13(11 Suppl 2), 2007
PMID: 17969090
A critical review of candidacy for orthotopic liver transplantation in alcoholic liver disease.
Kotlyar DS, Burke A, Campbell MS, Weinrieb RM., Am. J. Gastroenterol. 103(3), 2008
PMID: 18081918
Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease.
Sen S, Felldin M, Steiner C, Larsson B, Gillett GT, Olausson M, Williams R, Jalan R., Liver Transpl. 8(10), 2002
PMID: 12360442
Artificial liver support system combined with liver transplantation in the treatment of patients with acute-on-chronic liver failure.
Xu X, Liu X, Ling Q, Wei Q, Liu Z, Xu X, Zhou L, Zhang M, Wu J, Huang J, Sheng J, Zheng S, Li L., PLoS ONE 8(3), 2013
PMID: 23516546
Downgrading MELD improves the outcomes after liver transplantation in patients with acute-on-chronic hepatitis B liver failure.
Ling Q, Xu X, Wei Q, Liu X, Guo H, Zhuang L, Chen J, Xia Q, Xie H, Wu J, Zheng S, Li L., PLoS ONE 7(1), 2012
PMID: 22291934
Intensive care of the patient with cirrhosis.
Olson JC, Wendon JA, Kramer DJ, Arroyo V, Jalan R, Garcia-Tsao G, Kamath PS., Hepatology 54(5), 2011
PMID: 21898477
Should length of sobriety be a major determinant in liver transplant selection?
Rice JP, Lucey MR., Curr Opin Organ Transplant 18(3), 2013
PMID: 23492643
General Assembly resolution 217A
AUTHOR UNKNOWN, 0

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 25892898
PubMed | Europe PMC

Search this title in

Google Scholar